̽»¨ºÏ¼¯

Summary: Leveraging ̽»¨ºÏ¼¯â€™s expert formulation and dose design capabilities, Kemin Industries has developed a new to the segment nutritional supplement which includes their proprietary phenolic complex Neumentixâ„¢ derived from spearmint.

Summary: With over 80 years of global manufacturing expertise, ̽»¨ºÏ¼¯ has an extensive network of facilities to provide full service integrated softgel manufacturing and coating capabilities.

Summary: EasyBurst® chewable technology is an ideal platform to deliver active ingredients, without the need for water, using our advanced taste masked fills encapsulated in our proprietary softgel shells.

Summary: As your innovation partner, we will help you address your consumers’ needs by leveraging our differentiated softgel technologies and robust product library to give your brand a competitive advantage in the market.

Summary: Jeremy Trochu, Vice President and General Manager of Pharmaceutical Development Services at ̽»¨ºÏ¼¯, recently sat down for an interview...

Summary: Big Pharma used to ignore this segment of the market, but now developing orphan drugs to treat these rare diseases is an industry priority.

Summary: In this report, we will highlight the trends shaping the orphan-drug market, with a particular focus on expedited drug development. Expert insights on navigating development and manufacturing challenges with...

Summary: OneXpress is a single integrated solution that provides the fastest pathway from clinical development to commercial manufacturing. By taking a proactive approach and assessing production considerations early in development, our teams...

Summary: Explore how you can leverage ̽»¨ºÏ¼¯â€™s successful track record optimizing thousands of molecules, deep development expertise and broadest set of superior technologies to...

Summary: ̽»¨ºÏ¼¯ offers end-to-end spray drying solutions from early-phase development through to clinical supply, and scale-up to commercial finished dose forms.